The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 30, 2020

Filed:

Mar. 27, 2018
Applicant:

Regeneron Pharmaceuticals, Inc., Tarrytown, NY (US);

Inventors:

Gang Chen, Yorktown Heights, NY (US);

Changlin Dou, Yantai, CN;

James P. Fandl, LaGrangeville, NY (US);

Assignee:

Regeneron Pharmaceuticals, Inc., Tarrytown, NY (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/25 (2006.01); C12P 21/00 (2006.01); C12N 15/63 (2006.01); C12N 15/85 (2006.01); C07K 16/00 (2006.01);
U.S. Cl.
CPC ...
C12N 15/635 (2013.01); C07K 16/00 (2013.01); C12N 15/63 (2013.01); C12N 15/85 (2013.01); C12P 21/00 (2013.01); A01K 2217/05 (2013.01); C07K 2317/14 (2013.01); C07K 2317/21 (2013.01); C07K 2319/00 (2013.01); C12N 2830/00 (2013.01); C12N 2830/15 (2013.01); C12N 2830/42 (2013.01); C12N 2840/20 (2013.01);
Abstract

Compositions and methods for the inducible expression of genes in eukaryotic cells are provided. Expression of a nucleotide sequence of interest encoding a protein of interest is controlled by a regulatory fusion protein that consists of a transcription blocking domain and a ligand-binding domain. When a cognate ligand for the ligand-binding domain is present, transcription of the nucleotide sequence of interest is blocked. Upon removal of the cognate ligand, the nucleotide sequence of interest is transcribed. The method is useful for large scale bioreactor production of a desired protein of interest in eukaryotic cells.


Find Patent Forward Citations

Loading…